We are live on ! Find out more
Russell Investments Group

Russell Investments Group Portfolio holdings

AUM $114B
1-Year Est. Return 41.71%
This Fund
S&P 500
This Quarter Est. Return
+25.54%
1 Year Est. Return
+41.71%
3 Year Est. Return
+123.74%
5 Year Est. Return
+158.32%
10 Year Est. Return
AUM
$44.9B
AUM Growth
+$6.27B
Cap. Flow
-$1.67B
Cap. Flow %
-3.73%
Top 10 Hldgs %
15.71%
Holding
3,283
New
245
Increased
1,347
Reduced
1,242
Closed
169

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$68.2M
2
ISRG icon
Intuitive Surgical
ISRG
+$67.8M
3
ETN icon
Eaton
ETN
+$59.3M
4
AXTA icon
Axalta
AXTA
+$57.5M
5
WRK
WestRock Company
WRK
+$49.4M

Sector Composition

Rank Sector Weight
1 Technology 20.44%
2 Financials 13.44%
3 Healthcare 12.8%
4 Consumer Discretionary 11.68%
5 Communication Services 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETRN
2951
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$26K ﹤0.01%
3,242
MRNS
2952
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$26K ﹤0.01%
+2,606
New +$24K
CBAY
2953
DELISTED
Cymabay Therapeutics
CBAY
$25K ﹤0.01%
+7,306
New +$21.1K
GH icon
2954
Guardant Health
GH
$22.4B
$24K ﹤0.01%
296
PXLW icon
2955
Pixelworks
PXLW
$41M
$24K ﹤0.01%
640
-14,001
-96% -$605K
CULP icon
2956
Culp Inc
CULP
$42.7M
$23K ﹤0.01%
2,700
-37,925
-93% -$270K
ESQ icon
2957
Esquire Financial Holdings
ESQ
$1.12B
$23K ﹤0.01%
1,384
ESSA
2958
DELISTED
ESSA Bancorp
ESSA
$23K ﹤0.01%
1,701
-18,808
-92% -$243K
FULC icon
2959
Fulcrum Therapeutics
FULC
$286M
$23K ﹤0.01%
+1,300
New +$20.5K
RNAC icon
2960
Cartesian Therapeutics
RNAC
$265M
$23K ﹤0.01%
+278
New +$25.2K
LJPC
2961
DELISTED
La Jolla Pharmaceutical Company
LJPC
$23K ﹤0.01%
+5,568
New +$33.9K
LYTS icon
2962
LSI Industries
LYTS
$909M
$22K ﹤0.01%
+3,537
New +$20.4K
YARW
2963
Yarrow Bioscience, Inc. Common Stock
YARW
$112M
$22K ﹤0.01%
4
WES icon
2964
Western Midstream Partners
WES
$19.6B
$22K ﹤0.01%
1
-297,281
-100% -$2.46M
ATTO
2965
DELISTED
Atento S.A.
ATTO
$21K ﹤0.01%
3,488
IBA
2966
DELISTED
Industrias Bachoco SAB De C.V.
IBA
$21K ﹤0.01%
612
SIC
2967
DELISTED
Select Interior Concepts, Inc. Class A Common Stock
SIC
$21K ﹤0.01%
6,200
-5,100
-45% -$14.9K
RDI icon
2968
Reading International Class A
RDI
$35.2M
$20K ﹤0.01%
4,800
-40,766
-89% -$154K
CGC
2969
Canopy Growth
CGC
$402M
$19K ﹤0.01%
122
EVC icon
2970
Entravision Communication
EVC
$1.08B
$19K ﹤0.01%
13,687
AVTA
2971
DELISTED
Avantax, Inc. Common Stock
AVTA
$19K ﹤0.01%
+1,729
New +$21.7K
CHMI
2972
Cherry Hill Mortgage Investment Corp
CHMI
$103M
$18K ﹤0.01%
2,072
-30,414
-94% -$234K
GYRE icon
2973
Gyre Therapeutics
GYRE
$749M
$18K ﹤0.01%
+418
New +$19.6K
MBIO icon
2974
Mustang Bio
MBIO
$4.47M
$18K ﹤0.01%
+8
New +$18.7K
ACIU icon
2975
AC Immune
ACIU
$232M
$17K ﹤0.01%
2,652

Similar funds

Russell Investments Group's Q2 2020 Portfolio in Review

As of Q2 2020, Russell Investments Group held 3,283 positions worth $44.9B, up 16% from $38.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Russell Investments Group withdrew a net $1.67B in Q2 2020, closing 169 positions and reducing 1,242 holdings. Its most notable exit was Raytheon Company, an estimated $33.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Russell Investments Group opened a new position in Otis Worldwide worth $51.1M.

  • Russell Investments Group's largest Q2 2020 buy was Otis Worldwide: 901,820 shares worth $51.1M.
  • Russell Investments Group added most to Nike in Q2 2020, an estimated $68.2M increase.
  • Russell Investments Group's biggest Q2 2020 reduction was Equity Residential, cutting an estimated $98.5M.
  • Russell Investments Group fully exited Raytheon Company in Q2 2020, selling an estimated $33.1M.
  • Russell Investments Group's ten largest holdings make up 16% of its $44.9B portfolio in Q2 2020.
  • Russell Investments Group opened 245 new positions and closed 169 in Q2 2020.
  • Russell Investments Group's portfolio value rose 16% quarter-over-quarter to $44.9B.

Based on Russell Investments Group's 13F filing for Q2 2020, filed 5 Aug 2020.